Article

Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in…

medRxiv · 2024 · Ayanlaja, A. A.; Chang, M.; Lalwani, K.; Ioannou, M.; Wang, J.; Jagtap, S.; Yang, Y.; Gartrell, R. D.; Pratilas, C. A.; Schreck, K. C.

Key facts

Title Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma
First author Ayanlaja, A. A.; Chang, M.; Lalwani, K.; Ioannou, M.; Wang, J.; Jagtap, S.; Yang, Y.; Gartrell, R. D.; Pratilas, C. A.; Schreck, K. C.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.12.21.629454
Product codes mentioned PFT

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature